3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Hematologic Neoplasms
22
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia
5
Myelodysplastic Syndromes
4
Neoplasms
3
Mycoses
2
COVID-19
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Myeloproliferative Disorders
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Heart Failure
1
Esophageal Neoplasms
1
Disease Progression
1
Interventions
posaconazole
4
Caspofungin
4
Voriconazole
3
Fluconazole
3
Standard of Care
2
liposomal amphotericin B
1
Levofloxacin
1
Itraconazole
1
Drug Therapy
1
Amphotericin B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Mycoses
×
Standard of Care
×
Other hematologic neoplasm
×
Clear all
NCT03301597
2021-03-30
LAUNCH
Nohla Therapeutics, Inc.
Phase 2
Terminated
146 enrolled
NCT01254318
2016-11-02
TRAFIC
Merck Sharp & Dohme LLC
Completed
130 enrolled
5 charts